Network Point-Of-Care Glucose Testing Market Demand, Revenue Forecast and Interesting Opportunities from 2022 to 2030

The report “Network Point-of-Care Glucose Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Accu-Chek Inform II, StatStrip, HemoCue, BAROzen H Expert Plus, i-STAT, CareSens Expert Plus); By Region; Segment Forecast, 2021 – 2029” gives a detailed insight into current market dynamics and provides analysis on future market growth.

According to the research report published by Polaris Market Research, The global network point-of-care glucose testing market size is expected to reach USD 1.79 billion by 2029 according to a new study by Polaris Market Research.

The significant factors of the market, such as growing demand for data-based patient analysis, remote patient monitoring, and incorporation with advanced data transfer techniques, attribute to the market growth. In addition, increasing incidences of diabetes and other lifestyle-related diseases further foster the demand for network point-of-care testing. The incorporation of developed technologies such as Infrared and BLE and the existing restructuring of the products by several competitors is expected to drive the new product development and launches in the industry.

Request Sample Report of Network Point-Of-Care Glucose Testing Market @

Innovative advancements like optical devices and instruments have facilitated the significant information used for medical treatments. For instance, in January 2018, Roche introduced its new product, “Accu-check,” which enables a blood glucose monitoring system that presents a unique shred with a large easy-edge dosing region. Hence, in turn, these factors may accelerate growth for network point-of-care testing over the coming years.

Top Market Players

  • Hoffmann-La Roche Ltd.
  • Bayer AG/Ascensia Diabetes Care Holdings AG
  • Nova Biomedical
  • Abbott LLC (Lifescan Inc.)
  • Danaher

Request To Get Discount on this Network Point-Of-Care Glucose Testing Market @

Growth Drivers
The increasing prevalence of diabetes across the globe is leading to the network adoption of network point-of-care sugar testing, which accelerates market growth. These tests can effectively enhance the management of diseases, leading to the highest market penetration, especially in developing regions where the availability of timely medical care and the infrastructural facility is limited. Several physicians, patients, and health-aware citizens worldwide are using network point-of-care glucose testing accuracy for wellness and treatment of chronic diseases such as diabetes. According to the International Diabetic Federation (IDF), about 463 million adults between 20 and 79 had diabetes in 2019.

Polaris Market Research has segmented the network point-of-care glucose testing market report on the basis of product and region:


Network Point-of-Care Glucose Testing, Product Outlook (Revenue – USD Million, 2017 – 2029)

  • i-STAT
  • Accu-Chek Inform II
  • StatStrip
  • HemoCue
  • CareSens Expert Plus
  • BAROzen H Expert Plus

Inquire more about this report before purchase @

About Polaris Market Research

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Contact Us:

Polaris Market Research

Phone: 1–646–568–9980